We have had a long-term interest in the role of immune T cell reactivity directed against the most abundant component of CNS myelin, myelin proteolipid protein (PLP), and have previously shown that T cell reactivity to PLP in MS is restricted by certain HLA types (23). This evidence concerns the gene PLP1 and myeloid sarcoma.